Drug Profile
BDF 9198
Latest Information Update: 19 Jun 2001
Price :
$50
*
At a glance
- Originator Eli Lilly and Company
- Class
- Mechanism of Action Sodium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Heart failure